Chikunguru 2022: Lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) yakabvumidzwa neFood and Drug Administration yevarwere vakuru vane hombe B-cell lymphoma (LBCL) vane chirwere cherefractory kune yekutanga-mutsara chemoi.